Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP854684.RAnBO-Zetm4x-v5QnT6ewi7LyX7_S7KOmcMIx_jpM-1Gg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP854684.RAnBO-Zetm4x-v5QnT6ewi7LyX7_S7KOmcMIx_jpM-1Gg130_assertion type Assertion NP854684.RAnBO-Zetm4x-v5QnT6ewi7LyX7_S7KOmcMIx_jpM-1Gg130_head.
- NP854684.RAnBO-Zetm4x-v5QnT6ewi7LyX7_S7KOmcMIx_jpM-1Gg130_assertion description "[These lesions include hyperplastic-type aberrant crypt foci, hyperplastic polyps, sessile serrated adenomas, admixed polyps and serrated adenomas, and constitute the so-called 'serrated pathway', which is distinct from both the conventional adenoma-carcinoma pathway and the mutator pathway of hereditary non-polyposis CRC and is characterized by early involvement of oncogenic BRAF mutations, excess CpG island methylation (CIM) and subsequent low- or high-level DNA microsatellite instability (MSI).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854684.RAnBO-Zetm4x-v5QnT6ewi7LyX7_S7KOmcMIx_jpM-1Gg130_provenance.
- NP854684.RAnBO-Zetm4x-v5QnT6ewi7LyX7_S7KOmcMIx_jpM-1Gg130_assertion evidence source_evidence_literature NP854684.RAnBO-Zetm4x-v5QnT6ewi7LyX7_S7KOmcMIx_jpM-1Gg130_provenance.
- NP854684.RAnBO-Zetm4x-v5QnT6ewi7LyX7_S7KOmcMIx_jpM-1Gg130_assertion SIO_000772 17204027 NP854684.RAnBO-Zetm4x-v5QnT6ewi7LyX7_S7KOmcMIx_jpM-1Gg130_provenance.
- NP854684.RAnBO-Zetm4x-v5QnT6ewi7LyX7_S7KOmcMIx_jpM-1Gg130_assertion wasDerivedFrom befree-20140225 NP854684.RAnBO-Zetm4x-v5QnT6ewi7LyX7_S7KOmcMIx_jpM-1Gg130_provenance.
- NP854684.RAnBO-Zetm4x-v5QnT6ewi7LyX7_S7KOmcMIx_jpM-1Gg130_assertion wasGeneratedBy ECO_0000203 NP854684.RAnBO-Zetm4x-v5QnT6ewi7LyX7_S7KOmcMIx_jpM-1Gg130_provenance.